No difference in ICSI outcomes from cryopreserved testicular spermatozoa from patients with azoospermia or cryptozoospermia
Asian Journal of Andrology · 2026
DOI: 10.4103/aja202592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Andrology, 2026. Verfasst von Jin-Yan Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Andrology & Sichuan Human Sperm Bank, West China Second University Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Sperm Injections, Intracytoplasmic, Cryopreservation, Azoospermia, Spermatozoa. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Intracytoplasmic sperm injection (ICSI) with cryopreserved testicular spermatozoa retrieved via testicular sperm aspiration (TESA) or microdissection testicular sperm extraction (micro-TESE) is an effective treatment for azoospermia and cryptozoospermia. The current research on testicular sperm cryopreservation has primarily focused on comparing ICSI outcomes between fresh and frozen-thawed testicular spermatozoa. Another focus of these researches is evaluating treatment efficacy differences between ICSI using spermatozoa from patients with obstructive azoospermia (OA) versus non-obstructive azoospermia (NOA). However, few studies have investigated ICSI outcomes among patients with OA, NOA, and cryptozoospermia. This retrospective cohort study analyzed the data from 688 patients at Sichuan Human Sperm Bank (Chengdu, China) between September 2021 and April 2024, comparing cryopreservation efficacy, sperm utilization rate, ICSI outcomes, and delivery outcomes of cryopreserved testicular sperm suspensions in OA group ( n = 542), NOA group ( n = 114), and cryptozoospermia group ( n = 32). Post-thaw analysis revealed that the median sperm viability before and after freezing, as well as the viability ratio, did not differ among the three groups (all P > 0.05). Sperm utilization in NOA group (60.5%) was significantly higher (both P < 0.0001) compared with cryptozoospermia group (31.3%) and OA group (19.9%), while no significant difference was found between OA and cryptozoospermia groups ( P > 0.05). Of 162 couples undergoing ICSI, there were no differences in fertilization, clinical pregnancy, delivery, and miscarriage rates among patients with OA, NOA, and cryptozoospermia (all P > 0.05). In the cryptozoospermia group with five newborns, all were full-term with normal birth weights, but this group had the highest maternal pregnancy complication rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Reproductive Andrology & Sichuan Human Sperm Bank, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
- Key Laboratory of Birth Defects and Related Disease of Women and Children, Sichuan University, Ministry of Education, Chengdu 610041, China.
Zitieren
APA
Xu, J. Y., Li, D. M., Liu, B., Liu, S. S., Luo, X. F., Luo, C., Zhao, W. R., Liu, Y., Ying, L. J., Xian, Y., & Li, F. P. (2026). No difference in ICSI outcomes from cryopreserved testicular spermatozoa from patients with azoospermia or cryptozoospermia. Asian Journal of Andrology. https://doi.org/10.4103/aja202592
Vancouver
Xu JY, Li DM, Liu B, Liu SS, Luo XF, Luo C, et al. No difference in ICSI outcomes from cryopreserved testicular spermatozoa from patients with azoospermia or cryptozoospermia. Asian Journal of Andrology. 2026. doi:10.4103/aja202592
BibTeX
@article{Xu2026,
author = {Xu, Jin-Yan and Li, Ding-Ming and Liu, Bo and Liu, Sha-Sha and Luo, Xue-Feng and Luo, Chen and Zhao, Wen-Rui and Liu, Yuan and Ying, Li-Juan and Xian, Yang and Li, Fu-Ping},
title = {No difference in ICSI outcomes from cryopreserved testicular spermatozoa from patients with azoospermia or cryptozoospermia},
journal = {Asian Journal of Andrology},
year = {2026},
doi = {10.4103/aja202592}
}
EUVIMED